1. |
Chu-Shore CJ, Major P, Camposano S, <italic>et al</italic>. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia, 2010, 51(7): 1236-1241.
|
2. |
Curatolo P, Moavero R, de Vries PJ. Neurological and neuropsy chiatric aspects of tuberous sclerosis complex. Lancet Neurol, 2015, 14(5): 733-745.
|
3. |
Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neur, 2013, 49(4): 243-254.
|
4. |
刘静, 朴月善, 卢德宏. 结节性硬化相关基因及其表达产物的研究进展. 中华病理学杂志, 2010, 39(3): 210-212.
|
5. |
胡湘蜀, 李花, 刁芳明, 等. 癫痫患者 5572 例病因分析. 中华神经科杂志, 2012, 45(4): 244-248.
|
6. |
Hilaire C Lam, Julie Nijmeh, Elizabeth P Henske. New developments in the genetics and pathogenesis of tumours in tuberous sclerosis complex. J Pathol, 2017, 11(241): 219-225.
|
7. |
张志芳, 许燮萍, 贾莉娟, 等. 结节性硬化患儿脑电图及其与临床的关系. 临床神经电生理杂志, 2004, 13(1): 25-27.
|
8. |
Sharon Samueli, Anastasia Dressler, Gudrun Gröppel, <italic>et al</italic>. Everolimus in infants with tuberous sclerosis complex-related West syndrome: First results from a single-center prospective observational study. Epilepsia, 2018, 7(15): 1-5.
|
9. |
赵玉武, 孙晓江, 郑惠民, 等. 结节性硬化症诊断标准中不同临床表现发生率的研究. 临床神经病学杂志, 2006, 19(3): 170.
|
10. |
Mettin RR, Merkenschlager A, Bernhard MK, <italic>et al</italic>. Wide spectrum of clinical manifestations in children with tuberous sclerosis complex-follow-up of 20 children. Brain Dev, 2014, 36(4): 306-314.
|
11. |
Rosser T, Panigrahy A, McClintock W. The diverse manifestations of the tuberous sclerosis complex: a review. Semin Pediatr Neurol, 2006, 13(1): 27-36.
|
12. |
Sun SY. MTOR kinase inhibitors as potential cancer therapeutic drugs. Cancer Letters, 2013, 340(1): 1-8.
|
13. |
Evan J Hess, Kirsten A Moody, Alexandra L, <italic>et al</italic>. Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex. Epilepsia, 2017, 7(20): 1-8.
|